课题基金 / 基金详情

Matrix and Bioreactors for Human Lung Regeneration

Matrix and Bioreactors for Human Lung Regeneration
用于人肺再生的基质和生物反应器
批准号:
8601879
负责人:
LAURA E NIKLASON
金额:
$64.69万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-01-01 至 2016-12-31

项目摘要

项目成果

LAURA E NIKLASON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Advanced or end-stage lung diseases, such as pulmonary fibrosis, emphysema, and cystic fibrosis, are a major cause of morbidity and mortality in the United States. Although lung transplantation is a viable alternative for some patients, the 5-year survival rate of approximately 50% (primarily due to chronic allograft rejection and/or infection) limits this modality as a long-term therapy. Moreover, the scarcity of donated lungs and the short graft viability times post-expiant are major limitations. Thus, there is a desperate need both for understanding pathophysiologic mechanisms in chronic lung diseases as well as for devising innovative methods to repair or bioengineer functional lungs. Thus, this proposal will test the hypothesis that the lung extracellular matrix (ECM) drives the proper localization, differentiation, and function of lung cells and is the key contributor to normal lung repair and regeneration. With a long-term goal of regenerating a functional human lung, we propose to critically examine the constitutive makeup ofthe decellularized lung ECM and to develop new tools for assessing lung matrix structure and function. Further, we propose to develop a human lung bioreactor that allows for optimal preparation of decellularized human lung matrices while maintaining physiologic ventilation and perfusion. Among the questions to be addressed are: 1) what are the key components of lung ECM that drive cellular behavior and function? 2) How can we better assess the barrier function and structure of lung ECM? 3) Can we develop a bioreactor that will allow a human lung to be decellularized and subsequently recellularized while undergoing mechanical ventilation and vascular perfusion? Work in this UOl application will be instrumental forthe success ofthe Lung Regeneration Consortium, because we will generate a basic and comprehensive understanding ofthe lung matrix that is used as a substrate for lung growth. We will also develop tools and bioreactors that will enable other Consortium members to utilize and leverage our findings. RELEVANCE (See instructions): The relevance ofthis research is to begin studying the feasibility of regenerating a functional human lung in the laboratory. Studies proposed will comprehensively define the protein makeup ofthe normal human lung, will devise novel methods of imaging the cellular repopulation of human lung tissues, and will develop a novel bioreactor in which human lungs can be regenerated.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Biologically Selective Drug-Eluting Stent
  • 批准号:
    10183318
  • 项目类别:
  • 资助金额:
    $68.59万
  • 财政年份:
    2019
  • 负责人:
    LAURA E NIKLASON
  • 依托单位:
Engineered Tracheal Replacements
  • 批准号:
    9376650
  • 项目类别:
  • 资助金额:
    $64.62万
  • 财政年份:
    2017
  • 负责人:
    LAURA E NIKLASON
  • 依托单位:
Hyaluronan Coatings for Engineered Vessels
  • 批准号:
    9230431
  • 项目类别:
  • 资助金额:
    $61.91万
  • 财政年份:
    2016
  • 负责人:
    LAURA E NIKLASON
  • 依托单位:
Hyaluronan Coatings for Engineered Vessels
  • 批准号:
    9038008
  • 项目类别:
  • 资助金额:
    $61.96万
  • 财政年份:
    2016
  • 负责人:
    LAURA E NIKLASON
  • 依托单位:
海外基金